Morphine

Morphine is the prototypical opioid analgesic and the most abundant active alkaloid in opium, the dried latex obtained from the seed pods of the opium poppy, Papaver somniferum ^[1]. As a naturally occurring opiate it has served for centuries as a reference point against which other pain-relieving drugs are measured, and it remains one of the most effective medicines available for severe pain ^[1][2].

The pure compound was first isolated by the German pharmacist Friedrich Serturner in the opening years of the nineteenth century, an achievement often described as the first isolation of an active alkaloid from a plant; he named it after Morpheus, the Greek god of dreams, in reference to its sleep-inducing quality. Commercial manufacture began in the 1820s, and the drug's medical use spread rapidly after the mid-century introduction of the hypodermic syringe, which allowed it to be injected ^[1].

Morphine is used to treat moderate to severe pain of many kinds, including acute pain after surgery or injury, chronic pain, and the pain of cancer, and it has an established place in palliative care, where it is also used to relieve breathlessness ^[2]. Oral morphine, in both immediate-release and modified-release forms, is regarded as a standard treatment for moderate or severe cancer pain; a Cochrane review found that around nineteen in twenty patients who could tolerate it achieved no worse than mild pain ^[2]. It appears on the World Health Organization's Model List of Essential Medicines and is supplied as oral tablets and solutions, injectable preparations and other formulations, all available generically ^[2].

The benefits of morphine are inseparable from its hazards. It is a controlled substance in essentially every country, classified for example as a Schedule II drug in the United States, because repeated use produces tolerance and both physical and psychological dependence, and it carries a high potential for addiction ^[3]. In overdose its most dangerous effect is respiratory depression, a slowing of breathing that can be fatal; this can be reversed with the opioid antagonist naloxone ^[3]. Even at therapeutic doses it commonly causes constipation, nausea, drowsiness and other effects ^[4].

The dangerous part of morphine is respiratory depression; it makes you breathe slower and shallower, and in overdose breathing can stop altogether, which is how opioids kill. The overdose triad is pinpoint pupils, deep sedation you cannot rouse someone from, and slow or gurgling breathing; the antidote is naloxone, which knocks morphine off the receptor and can restart breathing, though it wears off faster than morphine and can throw a dependent person into sudden withdrawal. Everyday side effects include constipation (which barely fades with time, unlike most opioid effects), nausea and vomiting, itching from histamine release, drowsiness, urinary retention, and low blood pressure.

With repeated use the body builds tolerance, so more is needed for the same effect, and physical dependence, so stopping abruptly brings a miserable though rarely life-threatening withdrawal; genuine addiction can sit on top of that. The single most important interaction rule: never combine morphine with other central nervous system depressants. Benzodiazepines, alcohol, gabapentinoids, sleep medicines, and other opioids stack their breathing-suppressant effects on top of morphine's and are a leading cause of overdose death. Morphine is a Schedule II controlled substance in the United States, meaning it has accepted medical use alongside a high potential for abuse and dependence.

Morphine undergoes CYP3A4-mediated metabolism, so strong CYP3A4 inhibitors such as telaprevir reduce morphine clearance and elevate plasma levels, increasing overdose risk ^[5]. This is pharmacokinetic. Some opioids, particularly tramadol, carry both opioid and monoaminergic activity and can trigger serotonin toxicity when combined with serotonergic drugs including selective serotonin reuptake inhibitors ^[6]; however, morphine has not been shown to inhibit serotonin reuptake and is not among the opioids most commonly associated with this risk. Notably unstudied are morphine combinations with most antihistamines, anticholinergics, and non-SSRI antidepressants at clinically relevant doses.

Checking a whole stack? Run it through interactions + stacks.